NSEShareholders meeting22 Aug 2026 · 22 Aug 2026, 06:16 pm

Shareholders meeting

Par Drugs and Chemicals Limited · PAR

✦ AI Summaryshareholders_meeting

Par Drugs and Chemicals Limited has announced the 27th Annual General Meeting (AGM) to be held on September 26, 2026, at Hotel Tara Suns in Vadodara, Gujarat. The meeting will consider the audited standalone financial statements for the financial year ended March 31, 2026, and other business items.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026

Attachments (1)

📄

PAR_22082026181427_SignedIntimationof27AGM2026.pdf

pdf

Download →
View document text
PAR/CS/NSE/2026-27/16 Date: 22/08/2026 The Manager Listing department, National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra (E), Mumbai- 400 051 Maharashtra Subject: Intimation of 27th Annual General Meeting, Cut-off Date, e-voting period and other information Ref.: Symbol- PAR, ISIN: INE04LG01015 Dear Sir/Madam, Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform that the 27th Annual General Meeting of the members of the Company is scheduled to be as per followings: Meeting Number: 27th Annual General Meeting Date: 26th Day of September, 2026 Day: Saturday Venue: Hotel Tara Suns, B/h Yash Complex, B/s Sonal Park, G.E.R.I. Road, Gotri, Vadodara - 390021, Gujarat, India Time: 11:00 AM IST Mode: Physical The relevant dates w.r.t. Annual General Meeting are as under. Sr. Particulars Relevant Date 1. Cut-off/Record date: Friday, September 18, 2026 For the purpose of voting through remote e-voting, Venue voting at the time of the AGM and attending the AGM. 2. Commencement of E-voting Tuesday, 22nd September, 2026 from 09:00 A.M. IST onwards 3. End of e-voting Friday, 25th September, 2026 till 5:00 P.M. IST Page 1 of 2 The Company has arranged with MUFG INTIME INDIA PRIVATE LIMITED (Erstwhile known as Link Intime India Private Limited) (“RTA” of the Company) an agency for providing facility of e-voting for the ensuring AGM. The voting rights of the Members shall be in proportion to their shares of the paid up equity share capital of the Company, as on the cut-off date, being Friday, September 18, 2026 The above intimation shall be treated as due compliance of respective provisions under the Companies Act, 2013 and SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015. The Annual Report for F.Y. 2025-26 will be sent to shareholders and all concerned with due course. We request to take the same on your records and disseminate the same to the members. Kindly take on the record and acknowledge the receipt. Yours Faithfully, For PAR DRUGS AND CHEMICALS LIMITED (Mr. Sanket B. Trivedi) Company Secretary & Compliance Officer Membership No.: FCS-13800 Encl: Notice of 27th AGM Copy to: National Securities Depository Central Depository Services MUFG Intime India Private Limited (India) Limited Limited 4th Floor, Trade World, A Wing, “A” Wing, 25th Floor, Marathon Futurex, Office: 506 to 508 Amarnath Kamala Mills Compound, Mafatlal Mills Compounds, Business Centre, -1 (ABC-1), Senapati Bapat Marg, Lower Parel, N M Joshi Marg, Lower Parel (E), Besides Gala Business Centre, Mumbai – 400013 Mumbai – 400013 Near St. Xaviers College, Off C. G. Road, Navrangpura, Ahmedabad – 380009 Page 2 of 2 Par Drugs And Chemicals Limited CIN: L24117GJ1999PLC035512 Registered office: 815, Nilamber Triumph, Gotri Vasna Road, Vadodara-390007, Gujarat, India Phone no.: 0265-2991021, 0278-2447013 Website: www.pardrugs.com Email: investors@pardrugs.com NOTICE OF 27TH ANNUAL GENERAL MEETING TO MEMBERS Notice is hereby given that the Twenty Seventh (27th) Annual General Meeting (“AGM”) of the Members of PAR DRUGS AND CHEMICALS LIMITED (“the Company”) will be held on Saturday, 26th Day of September, 2026 at 11:00 A.M. at Hotel Tara Suns, B/h Yash Complex, B/s Sonal Park, G.E.R.I. Road, Gotri, Vadodara -390021, Gujarat, India to transact the following business to transact the following business: ORDINARY BUSINESS: ITEM NO.1: To receive, consider and adopt the Audited Standalone Financial Statements of the company for the financial year ended on 31st March, 2026 together with the report of the Board of Directors and Auditors thereon. ITEM NO.2: To appoint a Director in place of Mr. Jignesh Vallabhbhai Savani, Director & CEO (DIN: 00198203), who retires by rotation and being eligible offer himself for re-appointment. ITEM NO.3: To re-appoint statutory auditors of the Company and to fix their remuneration and in this regard to consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary resolution: “RESOLVED THAT pursuant to the provisions of Section 139 and all other applicable provisions, if any, of the Companies Act, 2013 and the Rules made thereunder, M/s. Sarupria Somani & Associates, Chartered Accountants (Firm Registration No.: 010674C) be and are hereby re-appointed as the Statutory Auditors of the Company from the conclusion of this 27th Annual General Meeting till the conclusion of the next 28th Annual General Meeting of the Company to be held for the F.Y. 2026-27 at an annual remuneration / fees of ₹ 2,25,000/- (Rupees Two Lakh Twenty Five Thousand Only) plus out of pocket expenses and taxes as applicable from time to time with the power to the Board/Audit Committee to alter and vary the terms and conditions of re-appointment, revision including upward revision in the remuneration during the remaining tenure.” “RESOLVED FURTHER THAT for the purpose of giving effect to the above resolution, the Board be and is hereby authorized to do all such acts, deeds, matters and things and take all such steps as may be necessary, proper or expedient for implementation of the above resolution and matters connected therewith or incidental thereto including but not limited to delegation of all or any of the powers herein conferred to any Committee or any director(s) or any other officer(s) of the Company, or to settle any 1 Par Drugs And Chemicals Limited | Annual General Meeting 2026 questions, difficulties or doubts that may arise with regard to the above resolution, without being required to seek any further clarification, consent or approval of the Members.” SPECIAL BUSINESS: ITEM NO.4: To approve the remuneration payable to Mr. Pravin Manjibhai Bhayani (DIN: 08332851) as an Independent Director of the Company and in this regard to consider and if thought fit, to pass, with or without modification (s), the following resolution as a Special resolution: “RESOLVED FURTHER THAT pursuant to the provisions of Section 149(9), 197(3) and 198 read with Schedule V and other applicable provisions, if any, of the Companies Act, 2013, Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 17(6)(ca) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any amendment/modification or re-enactment thereof) and pursuant to the recommendation and approval of the Nomination and Remuneration Committee and Audit Committee and the approval of the Board of Directors of the Company, consent of the Members of the Company be and is hereby accorded to for payment of remuneration to Mr. Pravin Manjibhai Bhayani (DIN: 08332851), Independent Director of the Company, amounting to ₹ 24 Lakhs (Rupees Twenty-Four Lakhs Only) for the period of one year w.e.f. 1st October, 2026 to 30th September, 2027, payable on a monthly, quarterly, half yearly or yearly basis, as decided by the Board of Directors of the Company. “RESOLVED FURTHER THAT the Board of Directors of the Company may pay the remuneration to Mr. Pravin Manjibhai Bhayani, Independent Director, DIN: 08332851 whether by way of remuneration, Commission or any other way and/ or any combination of the same as mutually agreed by the Board and Mr. Pravin Manjibhai Bhayani. “RESOLVED FURTHER THAT such remuneration shall exclude all the fees payable to Mr. Pravin Manjibhai Bhayani for attending the meetings of the Board and Committees of the Board and also exclude the expenses incurred/reimbursement of expenses for attending the meetings of the Board, the Committees, Shareholders and such other meetings as organized by the Company from time to time. “RESOLVED FURTHER THAT any present Directors of the company be and are hereby authorized to do sign/digitally sign all such necessary forms, documents, papers, and to do all such acts, matters, deeds as may be required under the Companies Act, [Showing first 8,000 characters — download PDF for full document]